OptimumBank Holdings, Inc. Financial Performance for the Second Quarter of 2026

OptimumBank Holdings (NYSE American: OPHC) reported Q2 2026 net income of $6.7M ($0.40 basic, $0.28 diluted), up from $4.7M in Q1 2026 and $3.6M in Q2 2025. For six months ended June 30, 2026 net income rose to $11.3M. Loans and deposits each grew about $126M and $121M QoQ to $1.2B. The company will host a webcast Aug. 13.

Original reporting
Published Jul 24, 2026, 12:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 24, 2026, 1:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$OPHC
Bullish
medium confidence
Mentioned
$OPHC
Relevance
8/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$OPHCBullishMed
01

Why it matters

The release updates OPHC’s quarterly earnings power and balance-sheet trajectory, highlighting improved net interest income, higher net interest margin, and continued loan and deposit growth, while credit losses remain modest.

02

Market read

Fresh Q2 earnings and operating metrics (net income, NIM, ROAA/ROAE, loan/deposit growth, credit loss reversal) provide a new basis for OPHC valuation and near-term positioning.

03

What to watch

The article notes noninterest expenses rose and credit loss reversal occurred alongside portfolio growth; traders may want to watch whether charge-offs normalize as the loan book expands and OptimumFinance scales.

Relevance 8/10Novelty 8/10Timing: Q2 2026 results released today, with webcast scheduled for Aug 13, 2026.

Background

OptimumBank Holdings is a Florida commercial bank holding company with non-bank subsidiaries including OptimumHUD Loans and OptimumFinance (HUD/bridge and financing).

Company-level read

Ticker impact

$OPHCBullishMedium confidence
Context

OptimumBank Holdings reported Q2 2026 net income of $6.7M, up from $4.7M in Q1, alongside higher NIM and loan and deposit growth.

Expected impact

Moderately positive near-term reaction, with follow-through risk if investors focus on expense growth or the sustainability of NIM/loan growth.

Evidence & confidence

The article provides fresh quarterly datapoints (income statement, NIM, ROAA/ROAE, loan/deposit growth, credit loss reversal) plus a new leadership transition and early-stage OptimumFinance activity, which can change expectations for earnings power.

Market effects

Adds datapoints on small-bank profitability drivers (NIM expansion, deposit growth, credit loss reversal) that can influence read-across sentiment for regional lenders.

Primarily impacts Florida-focused banking sentiment and local commercial real estate and HUD lending demand expectations.

Limited global impact; relevant mainly to US small-cap bank investors and rate-sensitive financials.

Counterpoint

Expense growth and the reliance on net interest income improvements could mean earnings are more rate and funding-cost sensitive than the headline net income suggests.

Key entities

  • OptimumBank Holdings, Inc.

    Reported Q2 2026 net income, NIM expansion, loan and deposit growth, and leadership transition effective May 1, 2026.

  • Moishe Gubin

    Became CEO effective May 1, 2026, after serving as Chairman for more than 16 years.

  • Braden R. Smith

    Joined as President effective May 1, 2026.

  • OptimumFinance, LLC

    Commenced activity in Q2 2026 and completed its first loan for $14.2M; expected to continue growing through 2026.

Related articles

$OPHCHigh

OptimumBank Holdings, Inc. Financial Performance for the Third Quarter of 2026

OptimumBank Holdings, Inc. (OPHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 OptimumBank Holdings, Inc. Financial Performance for the Third Quarter of 2026 Fort Lauderdale, FL, November 12, 2026 — OptimumBank Holdings, Inc. (NYSE American: OPHC) (the “Company”) is a financial holding company and owns 100% of OptimumBank (the “Bank”), a Florid

$OPHCMed

OptimumBank Holdings, Inc. Financial Performance for the Second Quarter of 2026

OptimumBank Holdings, Inc. (OPHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 OptimumBank Holdings, Inc. Financial Performance for the Second Quarter of 2026 Fort Lauderdale, FL, July 24, 2026 — OptimumBank Holdings, Inc. (NYSE American: OPHC) (the “Company”) is a financial holding company and owns 100% of OptimumB

$PTHSMed

Pelthos (PTHS) Q3 2026 Earnings Call Transcript

Pelthos (PTHS) reported Q3 2026 net revenue of $15.2M, up 114% YoY, with Zelsuvmi treating 31,000 patients. Formulary coverage expanded to 70% of commercial lives. The company announced a deal with Castle Creek Biosciences, aiming to leverage synergies in dermatology and cell/gene therapy markets. Xepi and Xeglyze launches are planned for 2027.

$BMNRMedAI 8/10

Bitmine’s ($BMNR) $6.3 Billion Loss Highlights Overall Risks for Strategy ($MSTR) and Other Treasury Firms as MSCI Tightens Rules

Bitmine Immersion Technologies (BMNR) reported a $6.3B net loss for fiscal 2026, driven by $6.23B in unrealized losses on digital-asset holdings, primarily ether. The company held 5.9M ether tokens and 211 bitcoin at year-end. Operating revenue was $125M, with staking contributing 97%. MSCI's updated index rules may impact BMNR and other crypto-focused treasury firms, including Strategy (MSTR).

HighAI 8/10

Merck KGaA Earnings Call Signals Stronger Growth Ahead

Merck KGaA (MKKGY) reported Q3 earnings with accelerated growth, raised full-year guidance, and announced strategic investments. Key highlights include 5.1% organic sales growth, EUR 1.66B operating cash flow, and plans to acquire Silence Therapeutics. Management emphasized growth in biomanufacturing, semiconductors, and rare diseases, while noting Mavenclad's declining sales and softer demand in consumer electronics.